Abstract
Pancreatic ductal adenocarcinoma is a common malignancy of the gastrointestinal tract. The number of new cases diagnosed and the number of deaths each year are almost identical, demonstrating the particularly dismal prognosis for patients affected by this disease. Despite recent advances in the field of medical and radiation oncology, and the introduction of neoadjuvant and adjuvant regimens, surgery remains the single most important modality for the treatment of pancreatic ductal adenocarcinoma. Surgery for pancreatic cancer is widely viewed as a complex procedure associated with considerable perioperative morbidity and mortality. Many aspects of surgery for pancreatic cancer, such as the extent of resection, the value of vascular resection, the use of laparoscopy, and the importance of treatment at high-volume centers, are currently under debate. This Review describes the current status of surgical treatment for pancreatic ductal adenocarcinoma, and highlights the new developments in this field.
Key Points
-
Pancreatic ductal adenocarcinoma is the fourth most common cause of cancer-related death, and the prognosis for patients with this disease is dismal
-
For patients with pancreatic cancer, complete surgical removal of the pancreatic tumor is the most important factor that determines survival
-
Patients treated at experienced centers demonstrate better short-term and long-term outcome; therefore, treatment should be performed by an experienced team
-
Vascular resections should be performed to achieve an R0 resection
-
Extended lymphadenectomy offers no survival benefit; however, extended resections are justified in order to achieve an R0 resection
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jemal A et al. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43–66
Bramhall SR et al. (1995) Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82: 111–115
van Heek NT et al. (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242: 781–788
Carpelan-Holmstrom M et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 54: 385–387
Kleeff J et al. (2006) Pancreatic cancer: from bench to 5-year survival. Pancreas 33: 111–118
Sobin LH and Wittekind C (2002) UICC: TNM classification of malignant tumours. (Sixth edition) London: John Wiley & Sons
Lockhart AC et al. (2005) Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 128: 1642–1654
Spanknebel K and Conlon KC (2001) Advances in the surgical management of pancreatic cancer. Cancer J 7: 312–323
Muller MW et al. (2006) Middle segmental pancreatic resection: an option to treat benign pancreatic body lesions. Ann Surg 244: 909–918
Kausch W (1912) Das carcinom der papilla duodeni und seine radikale entfernung [German]. Beitr Klin Chir 78: 439–486
Whipple AO et al. (1935) Treatment of carcinoma of the Ampulla of Vater. Ann Surg 102: 763–779
Gudjonsson B (1995) Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. J Am Coll Surg 181: 483–503
Trede M et al. (2001) Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 8: 595–610
Berberat PO et al. (1999) Prevention and treatment of complications in pancreatic cancer surgery. Dig Surg 16: 327–336
McKay A et al. (2006) Meta-analysis of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy. Br J Surg 93: 929–936
Wente MN et al. (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193: 171–183
Sikora SS and MC Posner (1995) Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg 82: 1590–1597
Yeo CJ et al. (1995) A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 222: 580–588
Hartel M et al. (2005) Effect of antecolic reconstruction on delayed gastric emptying after the pylorus-preserving Whipple procedure. Arch Surg 140: 1094–1099
Tani M et al. (2006) Improvement of delayed gastric emptying in pylorus-preserving pancreaticoduodenectomy: results of a prospective, randomized, controlled trial. Ann Surg 243: 316–320
Kleeff J et al. (2007) Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg 245: 573–582
Fernandez-del Castillo C et al. (1995) Standards for pancreatic resection in the 1990s. Arch Surg 130: 295–299
Lillemoe KD et al. (1999) Distal pancreatectomy: indications and outcomes in 235 patients. Ann Surg 229: 693–698
Knaebel HP et al. (2005) Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg 92: 539–546
Schwarz RE et al. (1999) The impact of splenectomy on outcomes after resection of pancreatic adenocarcinoma. J Am Coll Surg 188: 516–521
Aldridge MC and RC Williamson (1991) Distal pancreatectomy with and without splenectomy. Br J Surg 78: 976–979
Buchler MW et al. (2003) Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138: 1310–1314
Karpoff HM et al. (2001) Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 136: 44–47
Yeo CJ et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221: 721–731
Wagner M et al. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91: 586–594
Wagner M et al. (2001) Pylorus-preserving total pancreatectomy: early and late results. Dig Surg 18: 188–195
Fuhrman GM et al. (1996) Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223: 154–162
Harrison LE et al. (1996) Isolated portal vein involvement in pancreatic adenocarcinoma: a contraindication for resection? Ann Surg 224: 342–347
Leach SD et al. (1998) Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85: 611–617
Siriwardana HP and Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93: 662–673
Tseng JF et al. (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8: 935–949
Weitz J et al. (2007) Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 4: 712–716
Kondo S et al. (2003) Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body. Langenbecks Arch Surg 388: 101–106
Nakao A et al. (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg 30: 976–982
Ishikawa O et al. (1988) Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 208: 215–220
Manabe T et al. (1989) Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 64: 1132–1137
Michalski CW et al. (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94: 265–273
Riall TS et al. (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 3: update on 5-year survival. J Gastrointest Surg 9: 1191–1204
Schwarz RE and Smith DD (2006) Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol 13: 1189–1200
Pawlik TM et al. (2005) Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140: 584–589
Hishinuma S et al. (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10: 511–518
Watson K (1944) Carcinoma of the Ampulla of Vater: successful radical excision. Br J Surg 31: 368
Traverso LW and Longmire WP Jr (1978) Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146: 959–962
Yeo CJ et al. (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236: 355–366
Wenger FA et al. (1999) Gastrointestinal quality of life after duodenopancreatectomy in pancreatic carcinoma—preliminary results of a prospective randomized study: pancreatoduodenectomy or pylorus-preserving pancreatoduodenectomy [German]. Chirurg 70: 1454–1459
Lin PW et al. (2005) Pancreaticoduodenectomy for pancreatic head cancer: PPPD versus Whipple procedure. Hepatogastroenterology 52: 1601–1604
Seiler CA et al. (2000) Randomized prospective trial of pylorus-preserving vs. classic duodenopancreatectomy (Whipple procedure): initial clinical results. J Gastrointest Surg 4: 443–452
Tran KT et al. (2004) Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240: 738–745
Diener MK et al. (2007) A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245: 187–200
Horstmann O et al. (2004) Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection. Pancreas 28: 69–74
Pisters PW et al. (2001) Laparoscopy in the staging of pancreatic cancer. Br J Surg 88: 325–337
Ferrone CR et al. (2006) The influence of positive peritoneal cytology on survival in patients with pancreatic adenocarcinoma. J Gastrointest Surg 10: 1347–1353
Ammori BJ and Baghdadi S (2006) Minimally invasive pancreatic surgery: the new frontier? Curr Gastroenterol Rep 8: 132–142
Croce E et al. (2005) Laparoscopic surgery of pancreatic cancer: state of the art. Hepatogastroenterology 52: 1889–1894
Halloran CM et al. (2002) Complications of pancreatic cancer resection. Dig Surg 19: 138–146
Yeo CJ et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226: 248–257
Rumstadt B et al. (1998) Hemorrhage after pancreatoduodenectomy. Ann Surg 227: 236–241
Bassi C et al. (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138: 8–13
Alexakis N et al. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91: 1410–1427
van Berge Henegouwen MI et al. (1997) Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg 185: 18–24
Aranha GV et al. (2006) Current management of pancreatic fistula after pancreaticoduodenectomy. Surgery 140: 561–568
Friess H et al. (1996) Inhibition of secretion in pancreas surgery reduces postoperative complication rate: a meta analysis of 4 multicenter studies [German]. Langenbecks Arch Chir Suppl Kongressbd 113: 255–258
Poon RT et al. (2002) Prevention of pancreatic anastomotic leakage after pancreaticoduodenectomy. Am J Surg 183: 42–52
Buchler M et al. (1992) Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 163: 125–130
Montorsi M et al. (1995) Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 117: 26–31
Pederzoli P et al. (1994) Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 81: 265–269
Lowy AM et al. (1997) Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 226: 632–641
Yeo CJ et al. (2000) Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg 232: 419–429
Koukoutsis I et al. (2006) Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed. Dig Surg 23: 224–228
DeOliveira ML et al. (2006) Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244: 931–937
Winter JM et al. (2006) 1,423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10: 1199–1200
Weitz J et al. (2004) Impact of volume and specialization for cancer surgery. Dig Surg 21: 253–261
Birkmeyer JD et al. (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346: 1128–1137
Birkmeyer JD et al. (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349: 2117–2127
Birkmeyer JD et al. (2006) Volume and process of care in high-risk cancer surgery. Cancer 106: 2476–2481
Riall TS et al. (2006) Pancreatic cancer in the general population: improvements in survival over the last decade. J Gastrointest Surg 10: 1212–1224
Cameron JL et al. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244: 10–15
Riall TS et al. (2006) Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up. Surgery 140: 764–772
Cameron JL et al. (1993) One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 217: 430–435
Fong Y et al. (2005) Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242: 540–544
Ferrone CR et al. (2005) Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol 23: 7529–7535
Ferrone CR et al. (2006) Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 24: 2897–2902
Schniewind B et al. (2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93: 1099–1107
Koninger J et al. (2007) Surgical palliation in patients with pancreatic cancer. Langenbecks Arch Surg 392: 13–21
Lillemoe KD et al. (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230: 322–328
Raty S et al. (2006) Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: patient- and disease-related risk factors. Hepatogastroenterology 53: 133–137
Van Heek NT et al. (2003) The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238: 894–902
Bornman PC et al. (1986) Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1: 69–71
Shepherd HA et al. (1988) Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 75: 1166–1168
Andersen JR et al. (1989) Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 30: 1132–1145
Smith AC et al. (1994) Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet 344: 1655–1660
Reinders ME et al. (1995) Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors. World J Surg 19: 410–414
Lillemoe KD et al. (1996) Pancreaticoduodenectomy—does it have a role in the palliation of pancreatic cancer? Ann Surg 223: 718–725
Kuhlmann K et al. (2006) Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery 139: 188–196
Schniewind B et al. (2006) Bypass surgery versus palliative pancreaticoduodenectomy in patients with advanced ductal adenocarcinoma of the pancreatic head, with an emphasis on quality of life analyses. Ann Surg Oncol 13: 1403–1411
Kleeff J et al. (2007) Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245: 566–572
Shrikhande SV et al. (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14: 118–127
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Michalski, C., Weitz, J. & Büchler, M. Surgery Insight: surgical management of pancreatic cancer. Nat Rev Clin Oncol 4, 526–535 (2007). https://doi.org/10.1038/ncponc0925
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0925
This article is cited by
-
Prediction of clinically relevant postoperative pancreatic fistula using radiomic features and preoperative data
Scientific Reports (2023)
-
Pancreatectomy Combined with Arterial Resection for Pancreatic Carcinoma with Arterial Infiltration: A Meta-analysis
Indian Journal of Surgery (2021)
-
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
Langenbeck's Archives of Surgery (2020)
-
Pyloruserhaltende Pankreaskopfresektion
Der Chirurg (2016)
-
Total meso-pancreatoduodenum excision with pancreaticoduodenectomy in lower biliary tract cancer
Langenbeck's Archives of Surgery (2016)